TMO vs UHT · P/E 24, rev $44.56B vs P/E 30, rev $99.0M
Thermo Fisher Scientific Inc (TMO) versus Universal Health Realty Income Trust (UHT) — a side-by-side from cached financials, not a winner call.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Universal Health Realty Income Trust (UHT) is a reit - healthcare facilities company listed on NYSE.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Latest reported UHT revenue for 2024-12-31 was $99.0M. Net income was $19.2M. Revenue was up 3.6% from 2023-12-31 to 2024-12-31. UHT currently screens at market cap $538.0M and trailing P/E 30.3.
TMO currently screens at market cap $153.06B and trailing P/E 23.8. UHT currently screens at market cap $538.0M and trailing P/E 30.3.
Not investment advice. Open the TMO and UHT stock pages for the full models.
Not investment advice.